O'Shaughnessy Asset Management’s Acceleron Pharma XLRN Stock Holding History

O'Shaughnessy Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-191	Closed	-$33K	–	2803
2021 Q3	$33K	Buy	191 +1	+0.5%	+$131	﹤0.01%	1801
2021 Q2	$24K	Buy	190 +173	+1,018%	+$21.8K	﹤0.01%	1795
2021 Q1	$2K	Buy	17 +10	+143%	+$1.29K	﹤0.01%	2119
2020 Q4	$1K	Hold	7	–	–	﹤0.01%	2041
2020 Q3	$1K	Hold	7	–	–	﹤0.01%	1838
2020 Q2	$1K	Buy	+7	New	+$675	﹤0.01%	1695

O'Shaughnessy Asset Management's XLRN Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 191 shares — an estimated $33K sold.

O'Shaughnessy Asset Management first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $33K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 191 Acceleron Pharma shares in Q4 2021, an estimated $33K.
O'Shaughnessy Asset Management first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
O'Shaughnessy Asset Management's Acceleron Pharma position peaked at $33K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.